| dc.contributor.author | Malesker, Mark A. | en_US |
| dc.date.accessioned | 2014-06-27T13:41:05Z | |
| dc.date.available | 2014-06-27T13:41:05Z | |
| dc.date.issued | 2008 | en_US |
| dc.identifier.citation | Malesker, Mark A. Optimizing Antidiabetic Treatment Options for Patients with Type 2 Diabetes Mellitus and Cardiovascular Comorbidities. Pharmacotherapy. 2008, 02. 28(2):193-206. | en_US |
| dc.identifier.issn | 0277-0008 | en_US |
| dc.identifier.issn | 0277-0008 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10504/58669 | |
| dc.title | Optimizing Antidiabetic Treatment Options for Patients with Type 2 Diabetes Mellitus and Cardiovascular Comorbidities | en_US |
| dc.type | Journal Article | en_US |
| dc.description.volume | 28 | en_US |
| dc.title.work | Pharmacotherapy | en_US |
| dc.description.pages | 193-206 | en_US |
| dc.date.year | 2008 | en_US |
| dc.date.month | February | en_US |
| dc.description.issue | 2 | en_US |
| dc.program.unit | School of Pharmacy and Health Professions | en_US |
| dc.url.link1 | http://dx.doi.org/10.1592/phco.28.2.193 | en_US |
| dc.contributor.cuauthor | Malesker, Mark A. | en_US |
| dc.identifier.pmid | 18225965 | en_US |
